# Pilot Study of GVAX in Colorectal Cancer Cells

> **NCT01952730** · PHASE1 · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 1 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **BIOLOGICAL:** GVAX

## Key facts

- **NCT ID:** NCT01952730
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-11-08
- **Primary completion:** 2018-09
- **Final completion:** 2020-02
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Slow Accrual
- **Last updated:** 2023-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01952730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01952730, "Pilot Study of GVAX in Colorectal Cancer Cells". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01952730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*